top of page

Global Ashwagandha Market Surges, Shoden Sets the Standard

The global ashwagandha market visual media

The global ashwagandha market is flexing hard. Valued at USD 0.76 billion in 2025, it’s set to crack the USD 1 billion mark by 2030, tracking a solid 9.2% CAGR. Growth is fuelled by stress-fatigued consumers snapping up gummies, chews, and clean-label supplements; sports users chasing performance recovery blends; and beauty brands pulling ashwagandha into skincare for its antioxidant and anti-aging profile. North America dominates demand, but Asia-Pacific is sprinting ahead, with India exporting its Ayurvedic heritage into every corner of the wellness world.


Into this surging market steps Shoden, the flagship ashwagandha extract from Kerala’s Arjuna Naturals. Unlike standard formulations chasing “total withanolides,” Shoden delivers 35% withanolide glycosides, the compound profile now clinically proven to be the real driver of absorption and efficacy. A recent human study confirmed Shoden outperforms other extracts, with longer circulation of active compounds in the body, setting a new “bioavailability benchmark”, just as consumers demand science-backed credibility.


With 23 patents, 12 clinical studies, and distribution into 70+ countries, Arjuna is positioning Shoden as the gold-standard extract for supplement makers, functional food developers, and even skincare innovators looking for a reliable, low-dose adaptogen. As ashwagandha’s global wave builds, Shoden’s evidence-led story offers a clear differentiator in a crowded marketplace.



ENDS:

TOP STORIES

1/138
bottom of page